α-AR |
Alpha adrenergic receptor |
α1-AR |
Alpha 1 adrenergic receptor |
α2-AR |
Alpha 2 adrenergic receptor |
α-SMA |
Alpha smooth muscle actinin |
A2AR |
Adenosine receptor A2 |
A2BAR |
Adenosine receptor A2B |
A3AR |
Adenosine receptor A3A |
AC |
Adenylyl cyclase |
ACE |
Angiotensin converting enzyme |
ACS |
Acute coronary syndrome |
AKAP |
A-kinase anchoring protein |
AMI |
Acute myocardial infarction |
ANG II |
Angiotensin II |
AV block |
Atrio ventricular block |
BAD |
Bcl2 associated death promoter |
β-AR |
Beta adrenergic receptor |
β1-AR |
Beta 1 adrenergic receptor |
β2-AR |
Beta 2 adrenergic receptor |
β3-AR |
Beta 3 adrenergic receptor |
βARK1 |
Beta adrenergic receptor kinase 1 |
β-Ars |
Beta arrestins |
CAMKII |
Ca2+/Calmodulin-dependent protein kinase II |
cAMP |
Cyclic adenosine 3′-5′-monophosphate |
CaN |
Calcineurin |
CEC |
Cardiac excitation–contraction coupling |
CF |
Cardiac fibroblasts |
cGMP |
Cyclic guanosine-3′,5′-monophosphate |
CHD |
Coronary heart diseases |
CHID |
Chronic ischemic heart disease |
CICR |
Calcium-induced calcium release |
CNCC |
Cyclic nucleotide regulates cations channel |
CNGC |
Cyclic nucleotide-gated channels |
CNG |
Cyclic nucleotide-gated ion channels |
cNMP |
Cyclic nucleotide-3′,5′-monophosphate |
CTGF |
Connective tissue growth factor |
cTnT |
Cardiac Troponin T |
Drp1 |
GTPase dynamin related protein 1 |
eNOS |
Endothelial NO synthase |
EP3 |
Prostaglandin EP3 receptor |
EP4 |
Prostaglandin EP4 receptor |
Epac |
Exchange protein activated by cAMP |
ERK5 |
Extracellular signal-regulated kinase 5 |
FIS1 |
Mitochondrial fission 1 protein |
GCCR |
Glucagon receptor |
GEF |
Guanosine exchange factor |
GLP1 |
Glucagon-like peptide 1 |
GLP1R |
Glucagon-like peptide 1 receptor |
GPCR |
G protein-coupled receptor |
GRK2 |
G protein-coupled receptor kinase 2 |
GSK3β |
Glycogen synthase kinase 3 beta |
HCN |
Hyperpolarization-activated cyclic nucleotide–gated channels |
HF |
Heart failure |
HIF1α |
Hypoxia inducible factor 1alpha |
HR |
Heart rate |
I/R |
Ischemia/reperfusion |
ICEF |
Ischemia-induced caveolin 3 enriched fractions |
ICER |
Inducible cAMP early repressor |
KCNQ1 |
Potassium voltage-gated channel subfamily-Q member 1 |
LAD |
Left anterior descending artery ligation |
LTCC |
L-type calcium channel |
M2R |
Muscarinic receptor type 2 |
MEF2 |
Myocyte enhancer factor 2 |
MEK5 |
Mitogen-activated protein kinase kinase 5 |
MI |
Myocardial infarction |
miR-21 |
miRNA-21 |
MKK3 |
Mitogen-activated protein kinase 3 |
MLTK |
MLK-like mitogen-activated protein triple kinase |
mPTP |
Mitochondrial permeability transition pore |
MSCs |
Mesenchymal stem cells |
MyBPC |
Myosin binding protein C |
NAC |
N acetyl cysteine |
NCX |
Na/Ca exchanger |
NFATc3 |
Nuclear factor of activated T-cells, cytoplasmic 3 |
NO |
Nitric oxide |
PDE |
Phosphodiesterase |
PDK1 |
Pyruvate dehydrogenase kinase 1 |
PGE2 |
Prostaglandin E2 |
PI3K |
Phosphatidyl inositol-3 kinase |
PKA |
Protein kinase-A |
PKC |
Protein kinase-C |
PKD |
Protein kinase-D |
PKD1 |
Polycystic kidney disease 1 |
PKG |
Protein kinase G |
PKI |
Protein kinase-A inhibitor |
PLB |
Phospholamban |
PLC |
Phospholipase C |
PLK1 |
Polo-like kinase1 |
POPDC |
Popeye domain containing protein |
PP1 |
Protein phosphatase 1 |
PP2B |
Protein phosphatase 2B |
PPAR-γ
|
Peroxisome proliferator-activated receptor gamma |
PPI disruptors |
Protein–protein interaction disruptors |
PPs |
Protein phosphatases |
ROS |
Reactive oxygen species |
RSK3 |
Ribosomal S6 kinase |
RyR |
Ryanodin receptor |
sAC |
Soluble adenylyl cyclase |
SAN |
Sino atrial node |
SCD |
Sudden cardiac death |
SERCA2 |
Sarco/endoplasmic reticulum Ca2+-ATPase |
Siah2 |
Ubiquitin protein ligase seven in absentia homolog 2 |
SKIP |
Sphingosine kinase type 1-interacting protein |
smAKAP |
Small membrane A-kinase anchoring protein |
SNP |
Single-nucleotide polymorphism |
SR |
Sarcoplasmic reticulum |
STEMI |
ST elevation myocardial infarction |
TAC |
Transverse aortic constriction |
TnI |
Troponin I |